Article Text

  1. U Hennewig1,2,
  2. B Hadzik1,
  3. M Vogel1,
  4. T Meissner1,
  5. T Goecke3,
  6. H Peters4,
  7. G Selzer5,
  8. E Mayatepek1,
  9. T Hoehn1
  1. 1Department of General Pediatrics, University Hospital Duesseldorf, Duesseldorf, Germany
  2. 2Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany
  3. 3Institute of Human Genetics and Anthropology, University Hospital Duesseldorf, Duesseldorf, Germany
  4. 4Institute of Medical Genetics, Charité University Medicine, Berlin, Germany
  5. 5Department of Pediatric Intensive Care Medicine, Klinikum Bremen, Bremen, Germany


Congenital central hypoventilation syndrome (CCHS), a rare disorder typically presenting in the newborn period, results from PHOX2B polyalanine repeat mutations in over 90% of cases. It is characterized by alveolar hypoventilation, symptoms of autonomic nervous system dysregulation, and in a subset of cases Hirschsprung’s disease and later tumors of neural crest origin. We describe a preterm infant with severe phenotype of CCHS and hyperinsulinism. A novel de novo heterozygote missence mutation (Gly68Cys) in the PHOX2B gene could be identified. Based on the observation of three patients presenting with the combination of congenital hyperinsulinism and CCHS, hyperinsulinism might represent an additional clinical feature of CCHS.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.